These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9222089)
21. Inhibition of experimental proliferative vitreoretinopathy in rabbits by suramin. de Souza OF; Sakamoto T; Kimura H; Koda RP; Gabrielian K; Spee C; Ryan SJ Ophthalmologica; 1995; 209(4):212-6. PubMed ID: 8545096 [TBL] [Abstract][Full Text] [Related]
22. Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR). Pastor JC; Rodríguez E; Marcos MA; Lopez MI Ophthalmic Res; 2000; 32(1):25-9. PubMed ID: 10657752 [TBL] [Abstract][Full Text] [Related]
23. [Effects of hypericin on traumatic proliferative vitreoretinopathy in rabbits]. Gao Q; Hui Y; Wang Y Yan Ke Xue Bao; 2002 Dec; 18(4):240-5. PubMed ID: 15515769 [TBL] [Abstract][Full Text] [Related]
24. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Abrams GW; Azen SP; McCuen BW; Flynn HW; Lai MY; Ryan SJ Arch Ophthalmol; 1997 Mar; 115(3):335-44. PubMed ID: 9076205 [TBL] [Abstract][Full Text] [Related]
26. Retinoic acid-loaded alginate microspheres as a slow release drug delivery carrier for intravitreal treatment. Wang F; He S; Chen B Biomed Pharmacother; 2018 Jan; 97():722-728. PubMed ID: 29102915 [TBL] [Abstract][Full Text] [Related]
27. Influence of relaxing retinotomy on surgical outcomes in proliferative vitreoretinopathy. Tseng JJ; Barile GR; Schiff WM; Akar Y; Vidne-Hay O; Chang S Am J Ophthalmol; 2005 Oct; 140(4):628-36. PubMed ID: 16226515 [TBL] [Abstract][Full Text] [Related]
28. Porcine model of proliferative vitreoretinopathy with platelets. García-Layana A; Pastor JC; Saornil MA; Gonzalez G Curr Eye Res; 1997 Jun; 16(6):556-63. PubMed ID: 9192164 [TBL] [Abstract][Full Text] [Related]
29. Combining Sodium Hyaluronate and Polyvinylpyrrolidone Therapies for the Rabbit Cornea: A New Approach to Relief of the Human Dry Eye Syndrome. Ehrenberg M; Zolotariov E; Loeb E; Poliansky V; Levy A Curr Eye Res; 2015 Sep; 40(9):913-22. PubMed ID: 25329624 [TBL] [Abstract][Full Text] [Related]
30. Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10. Diddie KR; Azen SP; Freeman HM; Boone DC; Aaberg TM; Lewis H; Radtke ND; Ryan SJ Ophthalmology; 1996 Jul; 103(7):1092-9. PubMed ID: 8684799 [TBL] [Abstract][Full Text] [Related]
31. Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits. Yasukawa T; Kimura H; Tabata Y; Miyamoto H; Honda Y; Ogura Y Graefes Arch Clin Exp Ophthalmol; 2002 Aug; 240(8):672-8. PubMed ID: 12192462 [TBL] [Abstract][Full Text] [Related]
32. [Efficacy of 5-fluorouracil polyactic acid microsphere in prevention of proliferative vitreoretinopathy]. Bi HS; Cui Y; Zhang JH; Wang XR; Xie XF Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):37-41. PubMed ID: 16638279 [TBL] [Abstract][Full Text] [Related]
33. Retinoic acid suppresses the adhesion and migration of human retinal pigment epithelial cells. Du YH; Hirooka K; Miyamoto O; Bao YQ; Zhang B; An JB; Ma JX Exp Eye Res; 2013 Apr; 109():22-30. PubMed ID: 23428742 [TBL] [Abstract][Full Text] [Related]
34. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299 [TBL] [Abstract][Full Text] [Related]
35. Inflammatory responses after vitrectomy with vitreous substitutes in a rabbit model. Barth H; Crafoord S; Arnér K; Ghosh F Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):769-783. PubMed ID: 30656473 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy. Shinohara K; Tanaka M; Sakuma T; Kobayashi Y Ophthalmic Surg Lasers Imaging; 2003; 34(4):299-305. PubMed ID: 12875458 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment. Schnichels S; Schneider N; Hohenadl C; Hurst J; Schatz A; Januschowski K; Spitzer MS PLoS One; 2017; 12(3):e0172895. PubMed ID: 28248989 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy. Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404 [TBL] [Abstract][Full Text] [Related]
39. Transferrin-ricin A chain toxin limits the development of experimental proliferative vitreoretinopathy. Handa JT; Keithahn MA; Jaffe GJ Exp Eye Res; 1996 Jun; 62(6):689-96. PubMed ID: 8983950 [TBL] [Abstract][Full Text] [Related]
40. Attenuated glial reaction in experimental proliferative vitreoretinopathy treated with liposomal doxorubicin. Kuo HK; Chen YH; Wu PC; Wu YC; Huang F; Kuo CW; Lo LH; Shiea J Invest Ophthalmol Vis Sci; 2012 Jun; 53(6):3167-74. PubMed ID: 22491400 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]